0001062993-24-015384.txt : 20240819 0001062993-24-015384.hdr.sgml : 20240819 20240819172905 ACCESSION NUMBER: 0001062993-24-015384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240819 DATE AS OF CHANGE: 20240819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geist William CENTRAL INDEX KEY: 0001832210 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 241221909 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE STREET 2: C/O QUANTERIX CORPORATION CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-08-15 0000842023 BIO-TECHNE Corp TECH 0001832210 Geist William 614 MCKINLEY PL NE MINNEAPOLIS MN 55413 0 1 0 0 PRESIDENT, PROTEIN SCIENCES 0 Common Stock 4439 D Restricted Stock Units Common Stock 3320 3320 D Stock Options (Right to Buy) 100.39 2029-02-01 Common Stock 15912 15912 D Performance Restricted Stock Units Common Stock 7140 7140 D Performance Stock Options (Right to Buy) 94.52 Common Stock 22200 22200 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 29600 29600 D Performance Restricted Stock Units Common Stock 9074 9074 D Performance Stock Options (Right to Buy) 84.61 Common Stock 24424 24424 D Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 30059 30059 D Restricted Stock Units Common Stock 19823 19823 D Performance Restricted Stock Units 2024-08-15 4 A 0 15738 0 A Common Stock 15738 15738 D Restricted Stock Units 2024-08-15 4 A 0 7869 0 A Common Stock 7869 7869 D Stock Options (Right to Buy) 74.91 2024-08-15 4 A 0 21204 0 A 2034-08-15 Common Stock 21204 21204 D 3,320 restricted stock units previously reported in Table I have been moved to Table II and the Reporting Person's beneficial ownership has been updated accordingly. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 3,320 restricted stock units vest on 2/1/2025. Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. 9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027. Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. /s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed 2024-08-19